These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 12473603

  • 1. Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes.
    Lu J, Giuntoli RL, Omiya R, Kobayashi H, Kennedy R, Celis E.
    Clin Cancer Res; 2002 Dec; 8(12):3877-84. PubMed ID: 12473603
    [Abstract] [Full Text] [Related]

  • 2. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW, Liao CH, Ying C, Chang CJ, Lin CM.
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques.
    Villinger F, Miller R, Mori K, Mayne AE, Bostik P, Sundstrom JB, Sugimoto C, Ansari AA.
    Vaccine; 2004 Sep 03; 22(25-26):3510-21. PubMed ID: 15308379
    [Abstract] [Full Text] [Related]

  • 7. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY, Yang JY, Dou KF, Ma LY, Teng ZH.
    Hum Immunol; 2007 May 03; 68(5):334-41. PubMed ID: 17462500
    [Abstract] [Full Text] [Related]

  • 8. Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients.
    Rosenthal R, Groeper C, Bracci L, Adamina M, Feder-Mengus C, Zajac P, Iezzi G, Bolli M, Weber WP, Frey DM, von Holzen U, Oertli D, Heberer M, Spagnoli GC.
    J Immunother; 2009 Apr 03; 32(3):252-61. PubMed ID: 19242375
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4(+) T cells.
    Caserta S, Alessi P, Basso V, Mondino A.
    Eur J Immunol; 2010 Feb 03; 40(2):470-9. PubMed ID: 19950184
    [Abstract] [Full Text] [Related]

  • 11. IL-15 promotes survival but not effector function differentiation of CD8+ TCRalphabeta+ intestinal intraepithelial lymphocytes.
    Lai YG, Gelfanov V, Gelfanova V, Kulik L, Chu CL, Jeng SW, Liao NS.
    J Immunol; 1999 Dec 01; 163(11):5843-50. PubMed ID: 10570268
    [Abstract] [Full Text] [Related]

  • 12. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
    Dubsky P, Saito H, Leogier M, Dantin C, Connolly JE, Banchereau J, Palucka AK.
    Eur J Immunol; 2007 Jun 01; 37(6):1678-90. PubMed ID: 17492620
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells.
    Van Coppernolle S, Verstichel G, Timmermans F, Velghe I, Vermijlen D, De Smedt M, Leclercq G, Plum J, Taghon T, Vandekerckhove B, Kerre T.
    J Immunol; 2009 Oct 15; 183(8):4859-70. PubMed ID: 19801512
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 15; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 18. Signals required for programming effector and memory development by CD8+ T cells.
    Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, Hammerbeck CD, Popescu F, Xiao Z.
    Immunol Rev; 2006 Jun 15; 211():81-92. PubMed ID: 16824119
    [Abstract] [Full Text] [Related]

  • 19. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
    Rolle CE, Carrio R, Malek TR.
    Cancer Res; 2008 Apr 15; 68(8):2984-92. PubMed ID: 18413768
    [Abstract] [Full Text] [Related]

  • 20. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C, Nasorri F, Girolomoni G, Pità Od, Cavani A.
    Br J Dermatol; 2007 Aug 15; 157(2):249-58. PubMed ID: 17489975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.